Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schott

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2013
Predictors of recovery of ovarian function during aromatase inhibitor therapyN L Henry, R Xia, M Banerjee, et al.
The Journal of Pain|January 28, 2014
Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancerN Lynn Henry, Anna Conlon, Kelley M Kidwell, et al.
Annals of Surgical Oncology|August 5, 2005
Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsyAmina Khan, Michael S Sabel, Alexis Nees, et al.
Science (New York, N.Y.)|January 18, 1985
Subtropical atlantic climate studies: introductionR L Molinari, G A Maul, F Chew, et al.
Cancer Research|July 18, 2008
Monitoring serial changes in circulating human breast cancer cells in murine xenograft modelsJean-Pierre Eliane, Madeline Repollet, Kathryn E Luker, et al.
Cancer|March 13, 2019
Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202N Lynn Henry, Joseph M Unger, Cathee Till, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter StudyReshma Jagsi, Kent A Griffith, Jennifer R Bellon, et al.
Breast Cancer Research and Treatment|February 15, 2016
Clinical predictors of long-term survival in HER2-positive metastatic breast cancerPooja Murthy, Kelley M Kidwell, Anne F Schott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2009
Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancerTiffany H Svahn, Joyce C Niland, Robert W Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapyKuei C Lee, Bradford A Moffat, Anne F Schott, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2013
Predictors of recovery of ovarian function during aromatase inhibitor therapyN L Henry, R Xia, M Banerjee, et al.
The Journal of Pain|January 28, 2014
Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancerN Lynn Henry, Anna Conlon, Kelley M Kidwell, et al.
Annals of Surgical Oncology|August 5, 2005
Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsyAmina Khan, Michael S Sabel, Alexis Nees, et al.
Science (New York, N.Y.)|January 18, 1985
Subtropical atlantic climate studies: introductionR L Molinari, G A Maul, F Chew, et al.
Cancer Research|July 18, 2008
Monitoring serial changes in circulating human breast cancer cells in murine xenograft modelsJean-Pierre Eliane, Madeline Repollet, Kathryn E Luker, et al.
Cancer|March 13, 2019
Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202N Lynn Henry, Joseph M Unger, Cathee Till, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter StudyReshma Jagsi, Kent A Griffith, Jennifer R Bellon, et al.
Breast Cancer Research and Treatment|February 15, 2016
Clinical predictors of long-term survival in HER2-positive metastatic breast cancerPooja Murthy, Kelley M Kidwell, Anne F Schott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2009
Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancerTiffany H Svahn, Joyce C Niland, Robert W Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapyKuei C Lee, Bradford A Moffat, Anne F Schott, et al.
Pageof 7